Skip to main content
. 2019 Oct 14;9(10):e031697. doi: 10.1136/bmjopen-2019-031697

Table 2.

Trial inclusion and exclusion criteria

Inclusion criteria Exclusion criteria
Age≥18 years VA-ECMO after cardiac surgery for heart or lung–heart transplantation or ventricular assist device implantation
Intubated patients with cardiogenic shock treated with VA-ECMO VA-ECMO for acute poisoning with cardiotoxic drugs
Patients affiliated or beneficiaries of a social security scheme Pregnancy
Uncontrolled bleeding (bleeding despite medical intervention (surgery or drugs)
Implantation of VA-ECMO under cardiac massage with a duration of cardiac massage of ≥45 min
Out-of-hospital refractory cardiac arrest
Participation in another interventional research involving therapeutic modifications
Cerebral deficit with fixed dilated pupils
Patient moribund on the day of randomisation
Irreversible neurological pathology
Minor patients
Patients under tutelage

VA-ECMO, venoarterial extracorporeal membrane oxygenation.